Cutaneous Squamous Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Cutaneous Squamous Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-05-07Clinical Trial Update: Immunotherapy After Transplantation for Skin Cancer Prevention in Organ Transplant Recipients [Phase 2]
A Phase 2 trial evaluating immunotherapy after organ transplantation to prevent skin cancer in transplant recipients has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-05-07Clinical Trial Update: Immunotherapy Before Transplantation for Skin Cancer Prevention in Organ Transplant Recipients [Phase 2]
A Phase 2 trial evaluating immunotherapy before transplantation to prevent skin cancer in organ transplant recipients has been withdrawn, wi…
-
CLINICAL_TRIALS withdrawal · 2025-05-02Clinical Trial Update: Window of Opportunity Study of Topical Tranexamic Acid for Cutaneous Squamous Cell Carcinoma [Phase 2]
A Phase 2 window-of-opportunity trial evaluating topical tranexamic acid for cutaneous squamous cell carcinoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-07-26Clinical Trial Update: Study of Cemiplimab Alone or in Combination With Fianlimab and/or Other Experimental Agents in Adult Participants With Peri-operative Stage III/IV Cutaneous Squamous Cell Carcinoma (CSCC) [Phase 2]
A Phase 2 clinical trial evaluating cemiplimab alone or in combination with fianlimab (and other experimental agents) for peri-operative sta…
-
CLINICAL_TRIALS withdrawal · 2014-11-19Clinical Trial Update: Phase I/II Study of Postoperative Adjuvant Chemoradiation for Advanced-Stage Cutaneous Squamous Cell Carcinoma of the Head and Neck (cSCCHN) [Phase 1, Phase 2]
This Phase I/II trial evaluating postoperative adjuvant chemoradiation for advanced-stage cutaneous squamous cell carcinoma of the head and …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2012-07-25Clinical Trial Update: Dose-Ranging Safety and Efficacy Study of Topical Creams Containing API 31510 for the Treatment of in Situ Cutaneous Squamous Cell Carcinoma [Phase 2]
A Phase 2 dose-ranging safety and efficacy study of topical creams containing API 31510 for in situ cutaneous squamous cell carcinoma has be…